FASL is expressed in GBM cell lines and astrocytic brain tumors, and the intracranial delivery of FASL–FADD fusion amplicon concomitant to TMZ treatment enhances survival of mice by inducing apoptosis of tumor cells [180,181]. The gene discussed is FASLG; the disease is neoplasm.